• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白天血浆中优球蛋白溶解时间、组织型纤溶酶原激活物以及游离和总纤溶酶原激活物抑制剂水平的波动情况。

Fluctuations of euglobulin lysis time, tissue plasminogen activator, and free and total plasminogen activator inhibitor levels in plasma in daytime.

作者信息

Takada A, Takada Y, Urano T, Sakakibara K, Rydzewski A

机构信息

Department of Physiology, Hamamatsu University, School of Medicine, Shizuoka-ken, Japan.

出版信息

Thromb Res. 1990 Jan 1;57(1):13-20. doi: 10.1016/0049-3848(90)90191-e.

DOI:10.1016/0049-3848(90)90191-e
PMID:2105539
Abstract

Blood was taken from healthy 15 males and 10 females at 9:30 h, 10:00 h and 12:30 h. The euglobulin fraction was prepared and clotted by the addition of human thrombin. The clot lysis time shortened significantly from 9:30 h to 10:00 h (p less than 0.01) and further to 12:30 h (p less than 0.01). Plasma levels of tissue plasminogen activator (t-PA) antigens did not change from 9:30 h to 10:00 h, but slightly and significantly to 12:30 h (p less than 0.01). Plasma levels of free plasminogen activator inhibitor-1 (PAI-1) and complex of t-PA-PAI-1 decreased from 9:30 h to 10:00 h (p less than 0.02) and to 12:30 h (p less than 0.01). Plasma levels of total PAI-1 (free plus complex) decreased from 9:30 h to 10:00 h (p less than 0.01) and to 12:30 h (p less than 0.01). These results suggest that a major factor contributing to the enhanced fibrinolytic activity of the euglobulin fraction may be a level of PAI-1 (free and total).

摘要

在上午9:30、10:00和12:30采集了15名健康男性和10名健康女性的血液。制备优球蛋白组分,并通过添加人凝血酶使其凝固。从9:30到10:00,凝块溶解时间显著缩短(p<0.01),到12:30进一步缩短(p<0.01)。组织纤溶酶原激活物(t-PA)抗原的血浆水平从9:30到10:00没有变化,但到12:30有轻微且显著的变化(p<0.01)。游离纤溶酶原激活物抑制剂-1(PAI-1)和t-PA-PAI-1复合物的血浆水平从9:30到10:00降低(p<0.02),到12:30也降低(p<0.01)。总PAI-1(游离加复合物)的血浆水平从9:30到10:00降低(p<0.01),到12:30也降低(p<0.01)。这些结果表明,导致优球蛋白组分纤溶活性增强的一个主要因素可能是PAI-1(游离和总)的水平。

相似文献

1
Fluctuations of euglobulin lysis time, tissue plasminogen activator, and free and total plasminogen activator inhibitor levels in plasma in daytime.白天血浆中优球蛋白溶解时间、组织型纤溶酶原激活物以及游离和总纤溶酶原激活物抑制剂水平的波动情况。
Thromb Res. 1990 Jan 1;57(1):13-20. doi: 10.1016/0049-3848(90)90191-e.
2
Relationships between euglobulin clot lysis time and the plasma levels of tissue plasminogen activator and plasminogen activator inhibitor 1.优球蛋白凝块溶解时间与组织型纤溶酶原激活物及纤溶酶原激活物抑制剂1血浆水平之间的关系。
Thromb Haemost. 1990 Feb 19;63(1):82-6.
3
PAI-1 plays an important role in the expression of t-PA activity in the euglobulin clot lysis by controlling the concentration of free t-PA.纤溶酶原激活物抑制剂-1(PAI-1)通过控制游离组织型纤溶酶原激活物(t-PA)的浓度,在优球蛋白凝块溶解中t-PA活性的表达中发挥重要作用。
Thromb Haemost. 1991 Oct 1;66(4):474-8.
4
Fluctuation of tPA and PAI-1 antigen levels in plasma: difference of their fluctuation patterns between male and female.
Thromb Res. 1990 Oct 15;60(2):133-9. doi: 10.1016/0049-3848(90)90292-k.
5
Fluctuation of TPA and PAI-1 antigen levels in plasma: difference of their fluctuation patterns between male and female.血浆中组织型纤溶酶原激活物(TPA)和纤溶酶原激活物抑制剂-1(PAI-1)抗原水平的波动:男女之间波动模式的差异
Thromb Res. 1990 Oct 1;60(1):55-62. doi: 10.1016/0049-3848(90)90339-e.
6
Fibrinolysis during normal human pregnancy: complex inter-relationships between plasma levels of tissue plasminogen activator and inhibitors and the euglobulin clot lysis time.正常人类妊娠期间的纤维蛋白溶解:组织型纤溶酶原激活物及其抑制剂的血浆水平与优球蛋白凝块溶解时间之间的复杂相互关系。
Br J Haematol. 1988 Jun;69(2):253-8. doi: 10.1111/j.1365-2141.1988.tb07630.x.
7
[Decreased fibrinolytic capacity in coronary patients by increased plasminogen activator inhibitor activity].[冠状动脉疾病患者纤溶酶原激活物抑制剂活性增加导致纤溶能力下降]
Helv Chir Acta. 1992 Jan;58(4):503-8.
8
Diurnal variation of the fibrinolytic system.纤维蛋白溶解系统的昼夜变化。
Thromb Haemost. 1988 Jun 16;59(3):495-9.
9
Changes in plasminogen activator inhibitor 1 and tissue-type plasminogen activator during exercise in patients with coronary artery disease.冠状动脉疾病患者运动期间纤溶酶原激活物抑制剂1和组织型纤溶酶原激活物的变化。
Haemostasis. 1990;20(5):305-12. doi: 10.1159/000216142.
10
Fibrinolytic activity in retinal vein occlusion.视网膜静脉阻塞中的纤溶活性。
Int Ophthalmol. 1997;21(6):343-8. doi: 10.1023/a:1006075815099.

引用本文的文献

1
Antineoplastic agent busulfan regulates a network of genes related to coagulation and fibrinolysis.抗肿瘤药物白消安调节与凝血和纤溶相关的基因网络。
Eur J Clin Pharmacol. 2012 Jun;68(6):923-35. doi: 10.1007/s00228-011-1209-y.